3. Liver Interactions
Metformin’s primary action includes suppression of glucose production by the liver, which helps lower blood sugar levels in people with type 2 diabetes. While generally safe for those with healthy liver function, patients with pre-existing liver disease require careful monitoring because impaired liver function can influence metformin metabolism and increase risks.
Metformin does not typically cause direct liver damage, but liver enzyme tests are advisable before and during treatment to detect any abnormalities early. Inform your healthcare provider of any history of hepatitis, fatty liver disease, or other hepatic conditions prior to starting metformin.
4. Gastrointestinal Side Effects
Gastrointestinal symptoms are among the most common side effects of metformin, affecting up to 30% of users initially. These include diarrhea, nausea, abdominal discomfort, and flatulence. Symptoms usually appear soon after starting or increasing the dose and often improve over time.
To minimize discomfort:
- Take metformin with food.
- Begin with a low dose and titrate upward slowly.
- Consider extended-release formulations, which are better tolerated in many cases.
- Maintain adequate hydration to offset fluid loss from diarrhea.
If gastrointestinal symptoms persist or severely impact quality of life, discuss alternative dosing strategies with your healthcare provider.
5. Weight Management Impact
Metformin is sometimes noted for its modest effects on weight regulation. Some patients experience slight weight loss or appetite suppression, which may complement lifestyle efforts for blood sugar control. However, the degree of weight change varies widely and is influenced by diet, physical activity, and individual metabolic factors.
It is important not to rely solely on metformin for weight loss but to integrate it into a comprehensive approach that includes balanced nutrition and regular exercise. Discuss realistic goals and strategies with your healthcare team.
